http://www.mivtherapeutics.com
MIV Therapeutics Inc. (MIVT) is an advanced stage, research and development company pursuing the commercialization of the next-generation biocompatible coatings for stents and other medical devices, and advanced drug delivery systems with the intent of providing healing solutions for cardiovascular disease and other medical conditions. In collaboration with the University of British Columbia (UBC), the Company has developed coating technologies that utilize Hydroxyapatite (HAp) for application on medical devices and drug delivery systems. Simultaneously, alternative polymer-free coatings and advanced polymeric coatings with enhanced biocompatibility and bioavailability were developed at its wholly owned subsidiary, MIVI Technologies Inc. (Source: 10-K)
Kinetic Concepts, Inc. (KCI) is a global medical technology company that manages advanced wound care and therapeutic surfaces. The Company designs, manufactures, markets and services a range of products, which include advanced wound healing and tissue repair; pulmonary care and post cardiac arrest complications in the intensive care unit (ICU); bariatric care, and wound treatment and prevention. The advanced wound care systems incorporate the V.A.C. Therapy technology. Its therapeutic surfaces, including specialty hospital beds, mattress replacement systems and overlays, are designed to address pulmonary complications associated with immobility. KCI has an infrastructure designed to meet the specific needs of medical professionals and patients across all healthcare settings, including acute care hospitals, extended care organizations and patients' homes, both in the United States and abroad. In May 2008, KCI completed the acquisition of LifeCell Corporation.
Exactech, Inc. (Exactech) develops, manufactures, markets, distributes and sells orthopaedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians in the United States and internationally. Its revenues are principally derived from sales and distribution of its joint replacement systems, including knee, upper extremity, and hip implant systems, and distribution of biologic allograft services and bone cement materials used in orthopaedic surgery. Exactech manufactures some components of its knee, upper extremity and hip joint replacement systems at its facility in Gainesville, Florida utilizing modern, automated computer aided manufacturing equipment. On January 2, 2008, the Company exercised its option to acquire 100% of Altiva whereby Altiva became a wholly owned subsidiary of Exactech. On April 1, 2008, Exactech completed the acquisition of France Medica SAS, a French importer and distributor of orthopaedic products and surgical supplies.
Spacelabs Healthcare, Inc. is an international developer, manufacturer and distributor of medical equipment and services including patient monitoring solutions, anesthesia delivery and ventilation systems, diagnostic cardiology solutions and supplies and accessories selling to hospitals, clinics and physicians offices. Additionally, the Company provides electrocardiogram ("ECG") laboratory services to pharmaceutical companies undertaking clinical trials, whereby patient ECG data is recorded, analyzed, tabulated and interpreted. Spacelabs Healthcare combines a core of the world's most respected medical device and services companies with offices worldwide and distribution channels in over 100 countries.
Novadaq Technologies Inc. (Novadaq) develops and commercializes medical imaging devices for use in the operating room. Its imaging platform can be used to visualize blood vessels, nerves and the lymphatic system during surgical procedures. Novadaq’s first commercial product, the SPY System, allows surgeons to capture, review, print and archive high-quality fluorescent image sequences of the areas of interest, in real-time during complex surgical procedures. The OPTTX System is a single device that is designed to utilize Novadaq’s core imaging platform to diagnose ophthalmic vascular diseases in the back of the eye. In May 2007, Novadaq acquired certain business assets from Xillix Technologies Corp., including Xillix’s native tissue fluorescence, auto-fluorescence and multi modal imaging portfolio. Using this portfolio, Novadaq developed and launched, the PINPOINT endoscopic imaging system for autofluorescence. PINPOINT is the Company’s first minimally invasive imaging system.
Misonix, Inc. (Misonix) designs, manufactures, markets and develops minimally invasive ultrasonic medical device products. Misonix also develops and markets ultrasonic equipment for use in the scientific and laboratory markets, and ductless fume enclosures for filtration of gaseous contaminates in the laboratory and forensic markets. It operates in two business segments: laboratory and scientific products, and medical devices. Laboratory and scientific products include the Sonicator ultrasonic liquid processor, Aura ductless fume enclosure, the Labcaire Autoscope and Guardian endoscope disinfectant systems. Medical devices include the Auto Sonix ultrasonic cutting and coagulatory system, refurbishing revenues of high-performance ultrasound systems and replacement transducers for the medical diagnostic ultrasound industry, ultrasonic lithotriptor, ultrasonic neuroaspirator and soft tissue aspirator. On July 1, 2008, Misonix sold its equity portion in Focus Surgery, Inc. to USHIFU, LLC. (Source: 10-K)
Privacy Policy | Terms and Conditions | Do Not Sell My Personal Information | Websites Directory
Copyright © 2022 kwtbox.com. All Rights Reserved. US Business Directory